{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:59:48Z","timestamp":1775015988434,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ovarian cancer is the second most common gynaecologic malignancy and the main cause of death from gynaecologic cancer, due to late diagnosis and chemoresistance. Studies have reported the role of cysteine in cancer, by contributing for hydrogen sulphide (H<jats:sub>2<\/jats:sub>S) generation and as a precursor of glutathione (GSH). However, the role of cysteine in the adaptation to hypoxia and therapy response remains unclear. We used several ovarian cancer cell lines, ES2, OVCAR3, OVCAR8, A2780 and A2780cisR, to clarify cysteine relevance in ovarian cancer cells survival upon hypoxia and carboplatin. Results show that ES2 and OVCAR8 cells presented a stronger dependence on cysteine availability upon hypoxia and carboplatin exposure than OVCAR3 cells. Interestingly, the A2780 cisR, but not A2780 parental cells, benefits from cysteine upon carboplatin exposure, showing that cysteine is crucial for chemoresistance. Moreover, GSH degradation and subsequent cysteine recycling pathway is associated with ovarian cancer as seen in peripheral blood serum from patients. Higher levels of total free cysteine (Cys) and homocysteine (HCys) were found in ovarian cancer patients in comparison with benign tumours and lower levels of GSH were found in ovarian neoplasms patients in comparison with healthy individuals. Importantly, the total and S-Homocysteinylated levels distinguished blood donors from patients with neoplasms as well as patients with benign from patients with malignant tumours. The levels of S-cysteinylated proteins distinguish blood donors from patients with neoplasms and the free levels of Cys in serum distinguish blood from patients with benign tumours from patients with malignant tumours. Herein we disclosed that cysteine contributes for a worse disease prognosis, allowing faster adaptation to hypoxia and protecting cells from carboplatin. The measurement of serum cysteine levels can be an effective tool for early diagnosis, for outcome prediction and follow up of disease progression.<\/jats:p>","DOI":"10.1038\/s41598-018-27753-y","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T09:46:28Z","timestamp":1529315188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity"],"prefix":"10.1038","volume":"8","author":[{"given":"Sofia C.","family":"Nunes","sequence":"first","affiliation":[]},{"given":"Cristiano","family":"Ramos","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Lopes-Coelho","sequence":"additional","affiliation":[]},{"given":"Catarina O.","family":"Sequeira","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Gouveia-Fernandes","sequence":"additional","affiliation":[]},{"given":"Armanda","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Silveira","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Abreu","sequence":"additional","affiliation":[]},{"given":"V\u00edtor E.","family":"Santo","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Brito","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2653-2262","authenticated-orcid":false,"given":"Ana","family":"F\u00e9lix","sequence":"additional","affiliation":[]},{"given":"Sofia A.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Jacinta","family":"Serpa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"27753_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes Sebastian. Nat. Rev. 11, 719\u2013725 (2011).","journal-title":"Nat. Rev."},{"key":"27753_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"R Siegel","year":"2015","unstructured":"Siegel, R., Miller, K. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5\u201329 (2015).","journal-title":"CA Cancer J Clin"},{"key":"27753_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global Cancer Statistics, 2012. CA Cancer J Clin 65, 87\u2013108 (2015).","journal-title":"CA Cancer J Clin"},{"key":"27753_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc2946","volume":"10","author":"DD Bowtell","year":"2010","unstructured":"Bowtell, D. D. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10, 803\u2013808 (2010).","journal-title":"Nat Rev Cancer"},{"key":"27753_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.AOG.0000231680.58221.a7","volume":"108","author":"JK Chan","year":"2006","unstructured":"Chan, J. K. et al. Patterns and progress in ovarian cancer over 14 years. Obstet. Gynecol. 108, 521\u2013528 (2006).","journal-title":"Obstet. Gynecol."},{"key":"27753_CR6","doi-asserted-by":"crossref","unstructured":"Itamochi, H., Kigawa, J. & Terakawa, N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. 99, 653\u2013658 (2008).","DOI":"10.1111\/j.1349-7006.2008.00747.x"},{"key":"27753_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal, R. & Kaye, S. B. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 3, 502\u2013516 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"27753_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"CKM Ip","year":"2016","unstructured":"Ip, C. K. M., Li, S., Tang, M. H., Sy, S. K. H. & Ren, Y. Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress. Sci. Rep. 6, 1 (2016).","journal-title":"Sci. Rep."},{"key":"27753_CR9","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L","volume":"15","author":"MM Moradi","year":"1993","unstructured":"Moradi, M. M. et al. Serum and Ascitic Fluid Levels of Necrosis Factor-Alpha in Patients with Ovarian Epithelial Cancer. Cancer 15, 2433\u20132440 (1993).","journal-title":"Cancer"},{"key":"27753_CR10","first-page":"1066","volume":"48","author":"B Mills","year":"1988","unstructured":"Mills, B., Roifman, M. & Mellors, A. A Putative New Growth Factor in Ascitic Fluid from Ovarian Cancer Patients: Identification, Characterization, and Mechanism of Action\u2019. Cancer Res. 48, 1066\u20131071 (1988).","journal-title":"Cancer Res."},{"key":"27753_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI114784","volume":"86","author":"GB Mills","year":"1990","unstructured":"Mills, G. B. et al. Ascitic Fluid from Human Ovarian Cancer Patients Contains Growth Factors Necessary for Intraperitoneal Growth of Human Ovarian Adenocarcinoma Cells. J. Clin. Invest. 86, 851\u2013855 (1990).","journal-title":"J.Clin. Invest."},{"key":"27753_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"27753_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4161\/cc.10.2.14476","volume":"10","author":"J Serpa","year":"2011","unstructured":"Serpa, J. & Dias, S. Metabolic cues from the microenvironment act as a major selective factor for cancer progression and metastases formation. Cell Cycle 10, 180\u2013181 (2011).","journal-title":"Cell Cycle"},{"key":"27753_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"27753_CR15","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S. et al. Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance. Plos One 8 (2013).","DOI":"10.1371\/journal.pone.0079167"},{"key":"27753_CR16","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1073\/pnas.1306241110","volume":"110","author":"C Szabo","year":"2013","unstructured":"Szabo, C. et al. Tumor-derived hydrogen sulfide, produced by cystathionine- \u03b2 -synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. PNAS Pharmacol. 110, 12474\u201312479 (2013).","journal-title":"PNAS Pharmacol."},{"key":"27753_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","volume":"86","author":"S Sen","year":"2015","unstructured":"Sen, S. et al. Role of cystathionine \u03b2 -synthase in human breast Cancer. Free Radic. Biol. Med. 86, 228\u2013238 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"27753_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/pcmr.12312","volume":"28","author":"E Panza","year":"2015","unstructured":"Panza, E. et al. Role of the cystathionine \u03b3 lyase\/hydrogen sulfide pathway in human melanoma progression. Pigment Cell Melanoma Res. 28, 61\u201372 (2015).","journal-title":"Pigment Cell Melanoma Res."},{"key":"27753_CR19","doi-asserted-by":"publisher","first-page":"166.e15","DOI":"10.1016\/j.urolonc.2015.06.020","volume":"34","author":"JW Gai","year":"2016","unstructured":"Gai, J. W. et al. Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder. Urol. Oncol. Semin. Orig. Investig. 34, 166.e15\u2013166.e20 (2016).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"27753_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1667\/RR14177.1","volume":"185","author":"Y Pan","year":"2015","unstructured":"Pan, Y., Zhou, C., Yuan, D., Zhang, J. & Shao, C. Radiation Exposure Promotes Hepatocarcinoma Cell Invasion through Epithelial Mesenchymal Transition Mediated by H2S\/CSE Pathway. Radiat. Res. 185, 96\u2013105 (2015).","journal-title":"Radiat. Res."},{"key":"27753_CR21","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/1097-0142(20001001)89:7<1440::AID-CNCR5>3.0.CO;2-0","volume":"89","author":"T Schnelldorfer","year":"2000","unstructured":"Schnelldorfer, T. et al. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89, 1440\u20137 (2000).","journal-title":"Cancer"},{"key":"27753_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cbf.1149","volume":"22","author":"GK Balendiran","year":"2004","unstructured":"Balendiran, G. K., Dabur, R. & Fraser, D. The role of glutathione in cancer. cell Biochem. Funct. 22, 343\u2013352 (2004).","journal-title":"cell Biochem. Funct."},{"key":"27753_CR23","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1007\/s13277-015-4290-5","volume":"37","author":"F Lopes-Coelho","year":"2016","unstructured":"Lopes-Coelho, F. et al. HNF1B drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC). Tumor Biol. 37, 4813\u20134829 (2016).","journal-title":"Tumor Biol."},{"key":"27753_CR24","first-page":"28418511769999","volume":"0","author":"SG Mikalsen","year":"2017","unstructured":"Mikalsen, S. G., Jeppesen Edin, N., Sandvik, J. A. & Pettersen, E. O. Separation of two sub-groups with different DNA content after treatment of T-47D breast cancer cells with low dose-rate irradiation and intermittent hypoxia. Acta radiol. 0, 28418511769999 (2017).","journal-title":"Acta radiol."},{"key":"27753_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2016.10.002","volume":"101","author":"K Gutsche","year":"2016","unstructured":"Gutsche, K. et al. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-\u03baB in inflammatory breast cancer cells. Free Radic. Biol. Med. 101, 129\u2013142 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"27753_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","volume":"33","author":"GL Semenza","year":"2012","unstructured":"Semenza, G. L. Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 33, 207\u2013214 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"27753_CR27","doi-asserted-by":"publisher","unstructured":"Cutter, N. L., Walther, T., Gallagher, L., Lucito, R. & Wrzeszczynski, K. Hypoxia signaling pathway plays a role in ovarian cancer chemoresistance. In Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, https:\/\/doi.org\/10.1158\/1557-3265 (2016).","DOI":"10.1158\/1557-3265"},{"key":"27753_CR28","first-page":"1737","volume":"4","author":"J Kigawa","year":"1998","unstructured":"Kigawa, J., Minagawa, Y., Cheng, X. & Terakawa, N. y-Glutamyl cysteine synthetase up-regulates Multidrug resistance-associated protein in Patients with chemorresistant epithelial ovarian cancer. Clin. Cancer Res. 4, 1737\u20131741 (1998).","journal-title":"Clin. Cancer Res."},{"key":"27753_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573\u2013584 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"27753_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2144\/000113610","volume":"50","author":"SW Perry","year":"2011","unstructured":"Perry, S. W., Norman, J. P., Barbieri, J., Brown, E. B. & Harris, A. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50, 98\u2013115 (2011).","journal-title":"Biotechniques"},{"key":"27753_CR31","first-page":"438","volume":"19","author":"J Tammela","year":"1998","unstructured":"Tammela, J., Geisler, J., Eskew, P. J. & Geisler, H. Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma. Eur. J. Gynaecol. Oncol. 19, 438\u2013440 (1998).","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"27753_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ygyno.2011.05.009","volume":"122","author":"Y Lee","year":"2011","unstructured":"Lee, Y. et al. Gynecologic Oncology Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis. Gynecol. Oncol. 122, 541\u2013547 (2011).","journal-title":"Gynecol. Oncol."},{"key":"27753_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/gyno.1996.0065","volume":"417","author":"BA Goff","year":"1996","unstructured":"Goff, B. A. et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol. Oncol. 417, 412\u2013417 (1996).","journal-title":"Gynecol. Oncol."},{"key":"27753_CR34","doi-asserted-by":"crossref","unstructured":"Sugiyama, T. et al. Clinical characteristics of clear cell carcinoma of the ovary. Cancer 88 (2000).","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5"},{"key":"27753_CR35","doi-asserted-by":"crossref","unstructured":"Burgos-ojeda, D., Rueda, B. R. & Buckanovich, R. J. Ovarian cancer stem cell markers: Prognostic and therapeutic implications. 322, 1\u20137 (2012).","DOI":"10.1016\/j.canlet.2012.02.002"},{"key":"27753_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1196\/annals.1333.097","volume":"1043","author":"BS Szwergold","year":"2006","unstructured":"Szwergold, B. S., Howell, S. K. & Beisswenger, P. J. Transglycation\u2014A Potential New Mechanism for Deglycation of Schiff\u2019s Bases. Ann. N. Y. Acad. Sci. 1043, 845\u2013864 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"27753_CR37","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3945\/ajcn.115.125799","volume":"104","author":"EH Miranti","year":"2016","unstructured":"Miranti, E. H. et al. Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers. Am. J. Clin. Nutr. 104, 686\u2013693 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"27753_CR38","doi-asserted-by":"publisher","unstructured":"Gu\u0161tin, E., Jarc, E., Kump, A. & Petan, T. Lipid Droplet Formation in HeLa Cervical Cancer Cells Depends on Cell Density and the Concentration of Exogenous Unsaturated Fatty Acids. Acta Chim. Slov. 549\u2013554, https:\/\/doi.org\/10.17344\/acsi.2016.2908 (2017).","DOI":"10.17344\/acsi.2016.2908"},{"key":"27753_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso, J. A. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834\u2013846 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"27753_CR40","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1158\/0008-5472.CAN-13-1768","volume":"73","author":"O Lavi","year":"2013","unstructured":"Lavi, O., Greene, J. M., Levy, D. & Gottesman, M. M. The role of cell density and intratumoral heterogeneity in multidrug resistance. Cancer Res. 73, 7168\u20137175 (2013).","journal-title":"Cancer Res."},{"key":"27753_CR41","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1158\/0008-5472.CAN-15-3232","volume":"76","author":"JM Greene","year":"2016","unstructured":"Greene, J. M., Levy, D., Herrada, S. P., Gottesman, M. M. & Lavi, O. Mathematical modeling reveals that changes to local cell density dynamically modulate baseline variations in cell growth and drug response. Cancer Res. 76, 2882\u20132890 (2016).","journal-title":"Cancer Res."},{"key":"27753_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.bjc.6604802","volume":"100","author":"HL Tang","year":"2009","unstructured":"Tang, H. L., Yuen, K. L., Tang, H. M. & Fung, M. C. Reversibility of apoptosis in cancer cells. Br. J. Cancer 100, 118\u2013122 (2009).","journal-title":"Br. J. Cancer"},{"key":"27753_CR43","unstructured":"Mendis, S., Athauda, S. B. P. & Kenji, T. Association between hyperhomocysteinaemia and ischaemic heart disease in Sri Lankans. Int. J. Cardiol., 97\u2013103 (1997)."},{"key":"27753_CR44","doi-asserted-by":"publisher","first-page":"11123","DOI":"10.1158\/0008-5472.CAN-07-3061","volume":"67","author":"J Lin","year":"2007","unstructured":"Lin, J., Manson, J. E., Selhub, J., Buring, J. E. & Zhang, S. M. Plasma cysteinylglycine levels and breast cancer risk in women. Cancer Res. 67, 11123\u201311127 (2007).","journal-title":"Cancer Res."},{"key":"27753_CR45","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1158\/0008-5472.CAN-09-3648","volume":"70","author":"J Lin","year":"2010","unstructured":"Lin, J. et al. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res. 70, 2397\u2013405 (2010).","journal-title":"Cancer Res."},{"key":"27753_CR46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3945\/ajcn.112.049932","volume":"97","author":"JW Miller","year":"2013","unstructured":"Miller, J. W. et al. Homocysteine, cysteine, and risk of incident colorectal cancer in the Women\u2019 s Health Initiative observational cohort 1\u20133. Am J Clin Nutr 97, 827\u201334 (2013).","journal-title":"Am J Clin Nutr"},{"key":"27753_CR47","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.clnu.2013.11.007","volume":"33","author":"FF Chiang","year":"2014","unstructured":"Chiang, F. F. et al. High homocysteine is associated with increased risk of colorectal cancer independently of oxidative stress and antioxidant capacities. Clin. Nutr. 33, 1054\u20131060 (2014).","journal-title":"Clin. Nutr."},{"key":"27753_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gut.2010.225854","volume":"60","author":"G Murphy","year":"2011","unstructured":"Murphy, G. et al. Prospective study of serum cysteine levels and oesophageal and gastric cancers in China. Gut 60, 1\u20136 (2011).","journal-title":"Gut"},{"key":"27753_CR49","doi-asserted-by":"crossref","unstructured":"Traverso, N. et al. Role of Glutathione in Cancer Progression and Chemoresistance. Oxid. Med. Cell. Longev. 2013 (2013).","DOI":"10.1155\/2013\/972913"},{"key":"27753_CR50","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1089\/ars.2008.2089","volume":"10","author":"JJ Mieyal","year":"2008","unstructured":"Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A. & Shelton, M. D. Molecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation. Antioxid. Redox Signal. 10, 1941\u20131988 (2008).","journal-title":"Antioxid. Redox Signal."},{"key":"27753_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cbpa.2015.11.004","volume":"30","author":"M Visscher","year":"2016","unstructured":"Visscher, M., Arkin, M. R. & Dansen, T. B. Covalent targeting of acquired cysteines in cancer. Curr. Opin. Chem. Biol. 30, 61\u201367 (2016).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"27753_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2017.07.008","volume":"112","author":"JL Garc\u00eda-Gim\u00e9nez","year":"2017","unstructured":"Garc\u00eda-Gim\u00e9nez, J. L., Rom\u00e1-Mateo, C., P\u00e9rez-Machado, G., Peir\u00f3-Chova, L. & Pallard\u00f3, F. V. Role of glutathione in the regulation of epigenetic mechanisms in disease. Free Radic. Biol. Med. 112, 36\u201348 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"27753_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"ACR Epstein","year":"2001","unstructured":"Epstein, A. C. R. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43\u201354 (2001).","journal-title":"Cell"},{"key":"27753_CR54","doi-asserted-by":"publisher","unstructured":"Wu, D. & Yotnda, P. Induction and Testing of Hypoxia in Cell Culture. J. Vis. Exp., 4\u20137, https:\/\/doi.org\/10.3791\/2899 (2011).","DOI":"10.3791\/2899"},{"key":"27753_CR55","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.2849206","volume":"242","author":"MA Goldberg","year":"1988","unstructured":"Goldberg, M. A., Dunning, S. P. & Bunn, H. F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science (80-.) 242, 1412\u20131415 (1988).","journal-title":"Science (80-.)"},{"key":"27753_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jscs.2010.02.005","volume":"14","author":"MS Al Okail","year":"2010","unstructured":"Al Okail, M. S. Cobalt chloride, a chemical inducer of hypoxia-inducible factor-1\u03b1 in U251 human glioblastoma cell line. J. Saudi Chem. Soc. 14, 197\u2013201 (2010).","journal-title":"J. Saudi Chem. Soc."},{"key":"27753_CR57","doi-asserted-by":"crossref","unstructured":"Ghaly, A. E. & Kok, R. The effect of sodium sulfite and cobalt chloride on the oxygen transfer coefficient (1988).","DOI":"10.1007\/BF02921498"},{"key":"27753_CR58","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/0076-6879(95)60154-6","volume":"260","author":"M Reers","year":"1995","unstructured":"Reers, M. et al. Mitochondrial Membrane potential monitored by JC-1 Dye. Methods Enzymol. 260, 406\u2013417 (1995).","journal-title":"Methods Enzymol."},{"key":"27753_CR59","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2174\/138920309789630534","volume":"10","author":"MV Travedi","year":"2009","unstructured":"Travedi, M. V., Laurence, J. S. & Siahann, T. J. The role of thiols and disulfides in protein chemical and physical stability. Curr Protein Pept Sci. 10, 614\u2013625 (2009).","journal-title":"Curr Protein Pept Sci."},{"key":"27753_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejps.2017.05.010","volume":"105","author":"NM Grilo","year":"2017","unstructured":"Grilo, N. M. et al. Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms. Eur. J. Pharm. Sci. 105, 47\u201354 (2017).","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27753-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27753-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27753-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:45:35Z","timestamp":1671605135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27753-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27753-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9513"}}